Medicare Part D | DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

CMS oversight deficient Medicare

April 25, 2026 Evan Vega

CMS Oversight Found Lacking on Compounded Drugs in Medicare Part D, OIG Audit Reveals

An OIG audit found CMS lacked sufficient oversight of compounded drugs in Medicare Part D from 2017-2019 due to incomplete data and reporting gaps.